News
Investor's Business Daily on MSN39m
Why Drugmaker Teva Pharmaceutical Narrowed Full-Year Guidance After Beating Q2 EarningsGeneric drugs had a "stable" performance in the second quarter, with global revenue down about 2% in local currency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback